Healthcare & Life Sciences

Aetna CEO: “Doing Nothing, In the Current Model of Capitalism, Will Destroy Capitalism”

News & Press

Fuld & Company

In his article about the current model of capitalism during Aetna CVS merger talks, Clifton Reaf commented: Indeed, the Oracle of Delphi […]

Wearable Devices Provide a New Look for the Modern Clinical Trial

Blog Posts

Fuld & Company

Clinical development has historically been a laborious and expensive process, driven by lengthy patient recruitment timelines, increasingly complex study designs, […]

The Opioid Crisis: A Lesson in Adaptation

White Papers

There is an over-reliance on opioid medications within the U.S., with alarming increases in diversion, overdose, and addiction and it […]

Pharmacists as Vaccinators: New Entrant Disruption in Healthcare

White Papers

The U.S. human vaccines industry, projected to be $17.4 billion in 2018, is becoming more and more fragmented, with pharmacies […]

Pharmaceutical Perspective: Considerations When Tapping into A New Market

Blog Posts

The U.S. is the largest market for pharmaceuticals, accounting for 30 to 40 percent of the worldwide market. However, newer smaller markets […]

What Medical Marijuana Means for Pharma Companies

Blog Posts

Fuld & Company

Medical Marijuana, A Force to Be Reckoned With? A key player has emerged in the market that poses both threats […]

Injecting a New Healthcare Model: The Pharmacist-Physician Team

Blog Posts

With less than three years until the re-evaluation of HealthyPeople2020 Immunization targets, Benjamin Blumi, Senior Vice President of the American Pharmacists […]

Transparency into Drug Pricing: Can it Help with the High Drug Costs?

Blog Posts

Drug pricing became a topic of common and passionate interest in 2015 when Martin Shkreli, then CEO of Turing Pharmaceuticals, […]

What’s a Health Industry Business Strategist To Do?

Blog Posts

Fuld & Company

How do you set a business strategy in a highly-regulated market in which you don’t have complete control over what […]

Pharmaceutical Product Launch Pitfalls

White Papers

Fuld & Company

To be successful, a pharmaceutical product launch must address multiple challenges, such as having the sales force properly educated, aligned, […]

Six Reasons Why CVS Health Should Acquire Aetna … Soon

Blog Posts

, Fuld & Company

Should CVS consider acquiring a health plan? If yes, then which one? With a market-cap of about $80 billion and […]

Patient Compliance – The Next Challenge In Health Care Innovation

News & Press

One of the most complex and challenging situations facing today’s pharmaceutical industry is patient medication adherence and compliance. However, patient […]